
Teva Pharmaceutical Industries nudged up its full-year earnings guidance on Thursday, after reporting a drop in third-quarter profit that broadly met expectations.


Teva Pharmaceutical Industries nudged up its full-year earnings guidance on Thursday, after reporting a drop in third-quarter profit that broadly met expectations.